what is glp-1 ra receptor agonism: a transformative approach for managing type-2 diabetes and obesity | Saudi Pharmaceutical Journal GLP-1 receptor agonists and next-generation

Association between glucagon-like peptide-1 receptor agonists use and change in alcohol consumption: a systematic review

When should I take digestive bitters

Now, they may be opening an entirely new chapter in the treatment of addictive behaviors

While Ozempic can come in different forms, there are other similar drugs available as well, such as Victoza (liraglutide) and Byetta (exenatide)

In January 2025, the FDA approved an injectable form of semaglutide (Ozempic) specifically for managing chronic kidney disease in type 2 diabetes patients

that anxiety often stems from unclear records and fragmented clinic conversations rather than from any real detection risk